glp 1 medication and ms GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach GLP-1s and Multiple Sclerosis -

From traditional approaches like diet and exercise to advanced medical interventions, understanding the benefits and drawbacks of each can help you make an informed decision

Similar content being viewed by others Background Glucagon-like peptide-1 (GLP-1) is a peptide hormone known for its role in regulating glucose homeostasis and satiety

More than medication You are not just getting medication

Scientists are now investigating whether GLP-1 drugs could help treat substance use disorders, which also involve dopamine-driven reward pathways

Once the GLP-1s came out, they truly helped so many patients with metabolic disorders, especially diabetes and obesity, become healthier and improved the quality of their lives, Ganta says

These injections can help reduce unhealthy food cravings and increase feelings of satiation, both of which contribute to sustainable weight loss